全部分类
  • AZD8330
AZD8330的可视化放大

AZD8330

A MEK1/2 inhibitor

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

AZD8330的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 5mg
    ¥1075.00
    860.00
    - +
  • 10mg
    ¥1962.00
    1570.00
    - +
  • 50mg
    ¥5687.00
    4550.00
    - +
  • 100mg
    ¥7987.00
    6390.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajci13528
  • CAS: 869357-68-6
  • 别名: 2-(2-氟-4-碘苯氨基)-N-(2-羟基乙氧基)-1,5-二甲基-6-氧代-1,6-二氢吡啶-3-甲酰胺,ARRY-424704; ARRY-704; AZD-8330; ARRY424704; ARRY704; AZD8330
  • 分子式: C16H17FIN3O4
  • 分子量: 461.23
  • 纯度: >98%
  • 溶解度: ≥ 23.05mg/mL in DMSO
  • 储存: Store at -20°C
  • 库存: 现货

Background

AZD8330 is an orally active and selective MEK1/2 inhibitor with an IC50 of 7 nM. The inhibition of MEK1/2 by this component results in inhibition of growth factor-mediated cell signaling and tumor cell proliferation.


MEK, also known as MAP kinase kinase (MAP2K), is a kinase enzyme which phosphorylates mitogen-activated protein kinase (MAPK). The activation of MAPK signaling pathway was shown to be involved in regulation of various cell processes including cell proliferation, differentiation, apoptosis, metabolism and inflammation.


AZD8330 treatment was shown to cause cell apoptosis by suppressing the activation of ERK1/2 signal transduction pathway in Burkitt's lymphoma cell line Raji cells, which is in a dose and time dependent manner [1].


Recently, a large phase I trial of 82 patients with advanced tumor malignancies was conducted to define the maximum tolerated dose (MTD) and assessed the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8330. The MTD of this product was determined as 40mg/day [2].

参考文献:
1.? Feng K, Wang C, Zhou H, Yang J, Dong L, Zhou K, et al. [Effect of ERK1/2 inhibitor AZD8330 on human Burkitt's lymphoma cell line Raji cells and its mechanism]. Zhonghua Xue Ye Xue Za Zhi 2015,36:148-152.
2.? Cohen RB, Aamdal S, Nyakas M, Cavallin M, Green D, Learoyd M, et al. A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies. Eur J Cancer 2013,49:1521-1529.

Protocol

Cell experiment [1]:

Cell lines

MOS, U2OS, KPD, ZK58, 143b and Saos-2 cells

Preparation method

The solubility of this compound in DMSO is >10 mM. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below - 20 °C for several months.

Reacting condition

0 ~ 1 μM; 72 hrs

Applications

AZD8330 decreased viability of MOS and U2OS cells, and significantly affected 143b cells. In contrast, AZD8330 exhibited no effect on viability of KPD, ZK58 and Saos-2 cells. According to a capase3/7 activity assay, AZD8330 at the concentration of 0.5μM induced apoptosis in MOS and U2OS cells, but not in KPD and ZK58 cells.

参考文献:

[1]. Zuzanna Baranski, Tijmen H. Booij, Marieke L. Kuijjer, Yvonne de Jong, Anne-Marie Cleton-Jansen, Leo S. Price, Bob van de Water, Judith V. M. G. Bovée, Pancras C.W. Hogendoorn, Erik H.J. Danen. MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation. Genes Cancer. 2015 Nov; 6(11-12): 503–512.

没有评价数据

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算